mirtazapine has been researched along with Clerambault Syndrome in 2 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Mirtazapine has demonstrated superior tolerability to the tricyclic antidepressants, primarily on account of its relative absence of anticholinergic, adrenergic and serotonin-related adverse effects." | 5.31 | Occurrence of mirtazapine-induced delirium in organic brain disorder. ( Bailer, U; Fischer, P; Kasper, S; Küfferle, B; Stastny, J, 2000) |
| "Mirtazapine has demonstrated superior tolerability to the tricyclic antidepressants, primarily on account of its relative absence of anticholinergic, adrenergic and serotonin-related adverse effects." | 1.31 | Occurrence of mirtazapine-induced delirium in organic brain disorder. ( Bailer, U; Fischer, P; Kasper, S; Küfferle, B; Stastny, J, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yeh, YW | 1 |
| Chen, CY | 1 |
| Kuo, SC | 1 |
| Wang, TY | 1 |
| Wang, HY | 1 |
| Chen, CL | 1 |
| Bailer, U | 1 |
| Fischer, P | 1 |
| Küfferle, B | 1 |
| Stastny, J | 1 |
| Kasper, S | 1 |
2 other studies available for mirtazapine and Clerambault Syndrome
| Article | Year |
|---|---|
Mirtazapine treatment of periodic catatonia in organic mental disorder: a case report.
Topics: Adult; Antidepressive Agents, Tricyclic; Catatonia; Humans; Male; Mianserin; Mirtazapine; Neurocogni | 2010 |
Occurrence of mirtazapine-induced delirium in organic brain disorder.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Delirium; Depressive Disorder, Major; Fem | 2000 |